Caro A Z
Ann N Y Acad Sci. 1975 Jan 27;243:468-74. doi: 10.1111/j.1749-6632.1975.tb25389.x.
In fifteen patients affected by essential nonvibratory tinnitus, local applications in the external auditive canal of 2 ml medicated DMSO spray were made. The spray solution contained DMSO integrated with anti-inflammatory and vasodilatory substances. This application was repeated every four days for a month. At the same time each patient was administered a daily intramuscular injection of a preparation that contained DMSO and a vasodilatory component. The therapeutic effect was evaluated through the subjective modification of the symptom and functional tests of the auditory system. Of the fifteen patients treated, the tinnitus symptom completely disappeared in nine, and did not return during a one-year observation period. The patient's symptoms diminished in two cases, and in four cases the permanent tinnitus became occasional, triggered principally by environmental cold. It is important to note that among the concomitant signs, the five patients with vertigo noted improvement. Hypacusis diminished in three of the six patients affected. Insomnia disappeared in eight and diminished in seven cases. The rise in the average tympanic membrane temperature from 36.8 degrees C before to 37.9 degrees C after treatment was noteworthy. This could indicate an improvement of the blood flow in the inner ear.
在15例患有原发性非振动性耳鸣的患者中,在其外耳道局部应用了2毫升含药二甲基亚砜喷雾。喷雾溶液含有与抗炎和血管舒张物质结合的二甲基亚砜。每隔四天重复一次这种应用,持续一个月。与此同时,每位患者每天接受一次肌肉注射一种含有二甲基亚砜和血管舒张成分的制剂。通过症状的主观改变和听觉系统的功能测试来评估治疗效果。在接受治疗的15例患者中,9例耳鸣症状完全消失,且在一年的观察期内未复发。2例患者的症状减轻,4例持续性耳鸣变为偶发性耳鸣,主要由环境寒冷引发。需要注意的是,在伴随症状中,5例患有眩晕的患者症状有所改善。6例听力减退患者中有3例症状减轻。8例患者的失眠症状消失,7例患者症状减轻。值得注意的是,治疗后鼓膜平均温度从之前的36.8摄氏度升至37.9摄氏度。这可能表明内耳血流有所改善。